Vor Biopharma Inc.

Healthcare · Biotechnology · United States

Last price 19.53 USD (Oct 30, 2026, 2:45 PM EDT) · Market cap 1.16B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren’s disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and...